Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Optimi Health Corp (OP: OPTHF )

0.1491 -0.0092 (-5.81%)
Streaming Delayed Price Updated: 12:10 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,994
Open 0.1550
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1583
Today's Range 0.1488 - 0.1550
52wk Range 0.1303 - 0.4425
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... 
Via Benzinga
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
The exclusive sales partnership between psychedelics biotechs Mindset Pharma (OTCQB: MSSTF) and PharmAla Holdings resulted in the first sale of Mindset’s GMP-compliant psilocybin in Australia. 
Via Benzinga

Performance

YTD
-18.61%
-18.61%
1 Month
-6.81%
-6.81%
3 Month
-2.80%
-2.80%
6 Month
-32.66%
-32.66%
1 Year
-35.17%
-35.17%

More News

Read More
Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California
Via Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Via Benzinga
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
Via Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Via Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Via Benzinga
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Via Benzinga
Canada Update: Psychedelics Legal Landscape, Overview & Near-Term Predictions
Via Benzinga
Optimi Health Announces C$3.27 Million Private Placement with Strategic Investment from Lululemon Founder Chip Wilson
Via PressReach
Optimi Closes Non-Brokered Private Placement, Here Are The Details
Via Benzinga
Psychedelic Drugs Prove Their Worth In Clinical Trials
Via PressReach
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via PressReach
Topics Cannabis
Exposures Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Two Psychedelics Companies Will Study Effects Of Natural Psilocybin And MDMA In Healthy Volunteers
Via Benzinga
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA
Via PressReach
Topics Supply Chain
Exposures Supply Chain
Psychedelic Mushrooms Are Going Global: Supply Deal With UK-Based Wellness Company Moves Forward
Via Benzinga
Psychedelics May Make People Less Afraid of Death
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
Via Benzinga
Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics
Via Benzinga
Psychedelics Use Among Young Adults Reaches All-Time High
Via FinancialNewsMedia
First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details
Via Benzinga
Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead
Via Benzinga
Meet Blue Serenity, Canada's First Natural Therapeutic Psilocybin Product For Approved Patients
Via Benzinga
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.